MDWD

Mediwound Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 5/10
  • Momentum 4/10
Mediwound sales and earnings growth
MDWD Growth
Neutral
  • Revenue Y/Y 6.15%
  • EPS Y/Y 36.21%
  • FCF Y/Y 16.51%
Mediwound gross and profit margin trends
MDWD Profitability
Fair
  • Gross margin 18.50%
  • EPS margin -98.40%
  • ROIC -77.60%
Mediwound net debt vs free cash flow
MDWD Risk
Great
  • Debt / Equity 0.2
  • Debt / FCF 0.0
  • Interest coverage -4.9

Mediwound stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗